Dynamics of hepatitis B virus infection in vivo

Journal of Hepatology

Volumn 27, Issue 3, 1997, Pages 431-436

  Zeuzem, Stefan ^a   De Man, Robert A ^b   Honkoop, Pieter ^b   Roth, W Kurt ^c   Schalm, Solko W ^b   Schmidt, Jürgen M ^d  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

HBV replication; Hepatitis B virus; Kinetics; Lamivudine; Viral dynamics

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PLACEBO; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; FEMALE; HALF LIFE TIME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; OPEN READING FRAME; PRIORITY JOURNAL; STEADY STATE; TURNOVER TIME; VIREMIA; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

EID: 0030864783     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80345-5     Document Type: Article

References (33)

1. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem. 56:1981;651-693.
2. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet. 342:1993;1335-1340.
3. Bonino F, Hoyer B, Nelson J, Engle R, Verme G, Gerin J. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology. 1:1981;386-391.
4. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 267:1995;483-489.
5. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
6. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1996;1582-1586.
7. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
8. Zeuzem S, Schmidt JM, Lee J-H, Rüster B, Roth WK. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology. 23:1996;366-371.
9. Chang CN, Skalski V, Zhou JH, Cheng YC. Biochemical pharmacology of (+)- and (-)2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agents. J Biol Chem. 267:1992;22414-22420.
10. Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitiss B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA. 88:1991;8495-8499.
11. Severini A, Liu XY, Wilson JS, Tyrrel DL. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2′,3′-dideoxy-3′-thiacytidine. Antimicrob Agents Chemother. 39:1995;1430-1435.
12. de Man RA, Schalm SW, Main J, Thomas HC, Fevery J, Nevens F, et al. A dose ranging study to determine the antiviral activity and safety of lamivudine (2′deoxy-3′thiacytidine) in patients with chronic hepatitis B infection. Gut. 34:1993;S5. (suppl.).
13. Kuhns MC, McNamara AL, Cabai CM, Decker RH, Thiers V, Bréchot C, et al. A new assay for the quantitative detection of hepatitis B viral DNA in human serum. Zuckerman AJ. Viral Hepatitis and Liver Disease. 1988;258-262 A. R. Liss Inc. New York.
14. Kuhns MC, McNamara AL, Perrillo RP, Cabal CM, Campbell CR. Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy. J Med Virol. 27:1989;274-281.
15. Nelder JA, Mead R. A simplex method for function minimization. Computer J. 7:1965;308-313.
16. Johnson ML. Evaluation and propagation of confidence intervals in nonlinear, asymmetrical variance spaces: analysis of ligand-binding data. Biophys J. 44:1983;101-106.
17. Waits DG. Parameter estimates from nonlinear models. Johnson ML, Brand L. Methods in Enzymology. 1994;23-36 Academic Press, San Diego.
18. Sokal RR, Rohlf FJ. 2nd ed. Biometry - Statistical Tables. 1981;WH Freeman & Co, New York.
19. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical Recipes. 1989;Cambridge University Press, Cambridge.
20. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin MA. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 333:1995;1657-1661.
21. Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, et al. Randomized, controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology. 86:1984;150-157.
22. Zoulim F, Trepo C. Nucleoside analogs in the treatment of chronic viral hepatitis: efficiency and complications. J Hepatol. 21:1994;142-144.
23. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA. 93:1996;4398-4402.
24. Brown JL, Carman WF, Thomas HC. The clinical significance of molecular variation within the hepatitis B virus genome. Hepatology. 15:1992;144-148.
25. Zaaijer HL, ter Borg F, Cuypers HTM, Hermus MCAH, Lelie PN. Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol. 32:1994;2088-2091.
26. Miller R, Kaneko S, Chung C, Girones R, Purcell R. Compact organization of the hepatitis B virus genome. Hepatology. 9:1989;322-327.
27. Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 69:1995;5087-5094.
28. Monk RJ, Malik FG, Stokesberry D, Evans LH. Direct determination of the point mutation rate of a murine retrovirus. J Virol. 66:1992;3683-3689.
29. Pathak VK, Temin HM. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci USA. 87:1990;6019-6023.
30. vitro. J Biol Chem. 267:1992;24681-24688.
31. Klarmann GJ, Schauber CA, Preston BD. Template-directed pausing of DNA synthesis by HIV-1-reverse transcriptase during polymerization of HIV-1 sequences in vitro. Erratum J Biol Chem. 268:1993;13764.
32. Klarmann GJ, Schauber CA, Preston BD. Template-directed pausing of DNA synthesis by HIV-1-reverse transcriptase during polymerization of HIV-1 sequences in vitro. Erratum J Biol Chem. 268:1993;9793-9802.
33. Ricchetti M, Buc H. Reverse transcriptases and genomic variability: the accuracy of DNA replication in enzyme specific and sequence dependent. EMBO J. 9:1990;1583-1593.